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Abstract
The prevalence of human and animal helminth infections remains staggeringly high, thus urging the need for concerted
efforts towards this area of research. GABA receptors, encoded by the unc-49 gene, mediate body muscle inhibition in
Caenorhabditis elegans and parasitic nematodes and are targets of anthelmintic drugs. Thus, the characterization of
nematode GABA receptors provides a foundation for rational anti-parasitic drug design. We therefore explored UNC-49
channels from C. elegans muscle cultured cells of the first larval stage at the electrophysiological and behavioral levels.
Whole-cell recordings reveal that GABA, muscimol and the anthelmintic piperazine elicit macroscopic currents from UNC-49
receptors that decay in their sustained presence, indicating full desensitization. Single-channel recordings show that all
drugs elicit openings of ,2.5 pA (+100 mV), which appear either as brief isolated events or in short bursts. The comparison
of the lowest concentration required for detectable channel opening, the frequency of openings and the amplitude of
macroscopic currents suggest that piperazine is the least efficacious of the three drugs. Macroscopic and single-channel
GABA-activated currents are profoundly and apparently irreversibly inhibited by ivermectin. To gain further insight into
ivermectin action at C. elegans muscle, we analyzed its effect on single-channel activity of the levamisol-sensitive nicotinic
receptor (L-AChR), the excitatory receptor involved in neuromuscular transmission. Ivermectin produces a profound
inhibition of the frequency of channel opening without significant changes in channel properties. By revealing that
ivermectin inhibits C. elegans muscle GABA and L-AChR receptors, our study adds two receptors to the already known
ivermectin targets, thus contributing to the elucidation of its pleiotropic effects. Behavioral assays in worms show that
ivermectin potentiates piperazine-induced paralysis, thus suggesting that their combination is a good strategy to overcome
the increasing resistance of parasites, an issue of global concern for human and animal health.
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Introduction
GABA-gated chloride channels, members of the Cys-loop
receptor family, play an important inhibitory role in the nervous
system of vertebrates [1] and invertebrates [2]. Defective GABA
neurotransmission causes neurological disorders and GABAA
receptors are targets for therapeutically important drugs, including
benzodiazepines, barbiturates, and anesthetics [1,3,4]. In inverte-
brates, GABA receptors are important targets for insecticides and
nematicides [5]. GABA receptors are homo- or hetero-pentameric
proteins composed of an extracellular domain that carries the
agonist binding sites and a transmembrane region that forms the
ion pore [6–8]. The presence of a large number of GABA subunits
results in the formation of a wide variety of functionally and
pharmacologically different receptor subtypes [1].
In Caenorhabditis elegans, body wall muscles receive innervations
from both cholinergic (excitatory) and GABAergic (inhibitory)
motor neurons. Acetylcholine released from motor neurons
stimulates muscle contraction on one side of the body, and
simultaneously activates an inhibitory motor neuron that projects
to the opposite side of the body to release GABA. Thus, GABA
elicits muscle relaxation, facilitating the smooth body bend
necessary for coordinated locomotion [2]. Muscle cells contain
one GABA and two types of acetylcholine receptors (AChR), the
levamisole-sensitive (L-AChR) and the nicotine-sensitive AChR
(N-AChR). The C. elegans muscle GABA receptor is encoded by
the unc-49 gene, which is translated into three subunits: UNC-49A,
UNC-49B, and UNC-49C. In adult C. elegans, the GABA receptor
has been shown to be composed of UNC-49B and C subunits [9].
The UNC-49B subunit confers synaptic localization and allows
channel activation whereas UNC-49C is a non essential modu-
latory subunit that co-assembles with UNC-49B. The unc-49 null
mutant exhibits the ‘‘shrinker’’ phenotype, owing to hypercon-
traction of the body wall muscles on both sides of the body. The
worms become resistant to muscimol, which is a full agonist of
vertebrate GABAA receptors. This drug relaxes all body wall
muscles and causes lengthening of adult worms [10,11].
The unc-49 gene is also present in parasitic nematodes, including
Haemonchus contortus [12], Brugia malayi and Trichinella spiralis [13],
Ascaris suum and Loa loa [5], and GABA receptors are targets of
widely used anthelmintic agents. Within these agents, piperazine
(PZE) is the active constituent of over-the-counter remedies for
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threadworm infection in children. Its mode of action has been
primarily studied in A. suum, where its GABA-mimetic action
causes a flaccid, reversible paralysis of body wall muscle [14].
Ivermectin (IVM) has been used successfully to treat billions of
humans, livestock and pets. It activates glutamate-activated
chloride channels (GluClR) in nematodes and also activates and
modulates a great variety of vertebrate and invertebrate Cys-loop
receptors, including GABA receptors [15]. Understanding the
molecular basis of IVM wide spectrum of action may be important
for the development of novel anthelmintic agents.
UNC-49 receptors share significant structural and pharmaco-
logical overlap with mammalian GABAA receptors in some aspects
and differ greatly in others. These differences could be exploited in
parasitic drug design. However, information about functional
properties of nematode GABA receptors is still scarce. We
therefore here explored macroscopic and single-channel properties
of GABA receptors from C. elegans L1 muscle cells, determined
how they are activated and modulated by anthelmintic agents, and
evaluated the behavioral effects of these agents in the worm.
The characterization of GABA receptors in a genetically
tractable organism and model of parasitic nematodes provides
new avenues of exploration for selective drugs as well as for
defining structural determinants of activation and modulation in
the Cys-loop receptor family.
Materials and Methods
Caenorhabditis elegans strains
Nematode strains used: N2: Bristol wild-type; PD4251:
ccIs4251;dpy-20(e1282) which produces GFP in all body wall
muscles and vulval muscles; EG1653: oxIs22 [unc-49p::unc-49::GFP
+ lin-15(+)] psoralen integration of oxEx129 [unc-49Bp(long)::GFP +
lin-15(+)], which expresses GFP associated to UNC-49R [16]; and
the null mutants CB407: unc-49(e407) in which the UNC-49B
essential subunit is disrupted [16]; DA1316: avr-14(ad1302);avr-
15(ad1051);glc-1(pk54) in which a simultaneous mutation of three
genes, avr-14, avr-15, and glc-1, encoding glutamate-gated chloride
channel (GluCl) alpha-type subunits confers high-level resistance
to the antiparasitic drug ivermectin [17]. All nematodes strains
were obtained from the Caenorhabditis Genetic Center, which is
funded by the NIH National Center for Research Resources
(NCRR). Nematode strains were maintained at 18–25uC using
freshly prepared Nematode Growth Medium (NGM) petri dishes
that have been spread with Escherichia coli (OP50) as a source of
food [18,19].
Isolation and culture of C. elegans muscle cells
Cells were isolated and cultured as described before [18–20].
Briefly, adult nematodes were exposed to an alkaline hypochlorite
solution and eggs were treated with 1 unit/ml chitinase. The
dissociated embryo cells were filtered and placed on glass
coverslips coated with poly-O-Ornithine. Cultures were main-
tained at 22–24uC in a humidified incubator in L-15 medium
containing 10% fetal bovine serum. Complete differentiation to
the various cell types that comprise the newly hatched Larva 1 (L1)
was observed within 24 h as described by Christensen et al. [21].
Electrophysiological experiments were performed 1–5 days after
cell isolation.
Patch-clamp recordings
Single-channel currents were recorded in the cell-attached
patch configuration at 20uC [18,19]. The bath and pipette
solutions contained 140 mM NaCl, 3 mM CaCl2, 5 mM KCl,
5 mM MgCl2, 11 mM glucose, 5 mM HEPES (pH 7.4) for UNC-
49 receptors and 142 mM KCl, 5.4 mM NaCl, 1.8 mM CaCl2,
1.7 mM MgCl2, and 10 mM HEPES (pH 7.4) for L-AChRs.
Drugs were obtained from Sigma-Aldrich Co. The stock solution
for ivermectin (IVM) was prepared in dimethyl sulphoxide
(DMSO) and the final DMSO concentration used in all assays
was lower than 0.1%. Single-channel currents were recorded using
an Axopatch 200 B patch-clamp amplifier (Molecular Devices),
digitized at 5 ms intervals, and detected by the half-amplitude
threshold criterion using the TAC 4.0.10 program (Bruxton
Corporation). Open- and closed-time histograms were plotted
using a logarithmic abscissa and a square root ordinate and fitted
to the sum of exponential functions by maximum likelihood using
TACFit (Bruxton Corporation).
To recognize bursts and quantify their durations, a critical
closed time (tcrit) was defined as the point of intersection between
the briefest and the succeeding component, and openings
separated by closings briefer than this time constitute a burst
[22]. Typically, tcrit ranged from 0.15 to 0.20 ms. Burst duration
histograms were well described by the sum of two exponentials,
with the briefest duration component corresponding to isolated
events and the longest duration component, to bursts. The burst
duration was taken from the duration of the slowest component of
the burst duration histogram.
Macroscopic currents were recorded in the whole-cell config-
uration at 20uC at a holding potential of 270 mV [19]. The
pipette solution contained 134 mM KCl, 10 mM EGTA, 1 mM
MgCl2, and 10 mM HEPES (pH 7.3). The extracellular solution
(ECS) contained 140 mM NaCl, 3 mM CaCl2, 5 mM KCl,
5 mM MgCl2, 11 mM glucose, 5 mM HEPES (pH 7.4). The cell
membrane capacitance (Cm) was determined using the software
Windows Whole Cell Program (WinWCP; Strathclyde Institute of
Pharmacy and Biomedical Sciences, UK) after obtaining the
whole-cell configuration. All tested L1 muscle cells exhibited Cm
values varying from 2 to 6 pF. The perfusion system consisted of
solution reservoirs, manual switching valves, a four channel VC3
valve controller (ALA Scientific Instruments), a solenoid-driven
pinch valve, and three tubes (0.3 mm inner diameter) inserted into
the culture dish [23,24]. One tube contained the ECS alone and
the others, ECS with drugs. The cell was positioned within several
hundred microns of the three output tubes where streams coming
from them would intersect. The solution exchange time was
estimated by the open pipette method, by stepping the patch held
at 0 mV in ECS and then applying a 2000-ms pulse of ECS
diluted 1:1 with water. Typical exchange times ranged from 1 to
2 ms. Macroscopic currents were filtered at 5 kHz, digitized at
20 kHz, and analyzed using WinWCP. Each current represents
the average from 2–4 individual traces obtained from the same
cell, which were aligned with each other at the point where they
reached 50% of maximum. Peak currents (Ipeak) correspond to
the value obtained by extrapolation of the decay to this point. The
rise time of the currents (t20–80) was determined by calculating
the time in which the current increased from 20 to 80% of the
peak amplitude. Decays were fitted by a double-exponential
function:
I tð Þ~I1 e
{ ttf
 
zI2 e
{ ttsð ÞzIss ðEquation1Þ
Where Iss is the steady state current, and tf and ts, the decay time
constants.
Confocal Microscopy
Cells were grown in cultured dishes from MatTek (glass bottom
culture dishes Nº 0 MatTek Corporation, Ashland, MA, U.S.A).
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Fluorescence images were obtained by laser scanning confocal
microscopy (Leica TCS SP2) with a 63X water objective. Images
were collected and processed with LCS software (Leica) and
Photoshop (Adobe Systems, San Jose, CA). The percentage of
green cells was determined by counting cells in ten different fields
for each dish (n = 3 dishes). The result is expressed as the mean 6
SD from three different cell isolations. Quantitative analysis of
GABA receptor distribution was conducted by measuring the
intensity profile along the cell on the focal plane of the membrane
by using LCS software (Leica). An arbitrary 7.5 mm line was traced
through the cell starting and ending it in a background zone and a
curve of fluorescence intensity was constructed for each point of
the line.
Motility assays
Assays were performed with young adult hermaphrodites or L1
worms from synchronized plates. Measurement of drug
sensitivity. Paralysis was determined on agar plates containing
the tested drug at room temperature as described before [19].
Body paralysis was followed by visual inspection at the indicated
time (every 30–60 minutes) and was defined as the lack of
complete body movement in response to prodding. We evaluated
different types of nematode paralysis: flaccid that is mediated by
inhibitory stimulation, in which worms appear lengthened; spastic
paralysis that is mediated by AChR stimulation and worms appear
shorter [19,25], and stationary, in which worms do not show either
flaccid or spastic paralysis. Stationary worms retain normal
muscular rigidity and the capability of responding to prodding
by contracting body wall muscle [26].
Thrashing assay. individual young adult C. elegans were
placed in 200 ml of M9 buffer in the absence or presence of the
drug in a 96-well microlitre plate. After 30 minutes in the solution
at room temperature, the number of thrashes (bends of the body
from one side to the other) were counted during 1 minute [19].
The experiments were repeated 3 times for each condition (10
worms tested each time).
Statistics
Experimental data are shown as mean 6 S.D. Statistical
comparisons were done using the Student’s t test or one-way
ANOVA with Bonferroni’s multiple comparison post test. A level
of p,0.05 was considered significant.
Results
L1 muscle cells respond to GABAergic agonists
Cultured muscle cells corresponding to the Larva 1 stage (L1)
can be identified by their spindle-shaped morphology (Fig.1; [21]).
In the PD4251 strain, which produces GFP in all body wall and
vulval muscles, muscle cells can be easily distinguished by
fluorescence microscopy (Fig. 1A, right panel). Confocal micros-
copy observation of cultures obtained from the EG1653 strain,
which expresses GFP associated with GABA receptors [16], shows
that 78610% of cultured cells with spindle-shaped morphology
express GABA receptors, which appear to be homogeneously
distributed on the cell membrane (Fig. 1B and C).
To verify that L1 muscle cells express functional GABA
receptors, we measured macroscopic currents elicited by GABA
in the whole-cell configuration at 270 mV pipette potential. In
the control PD4251 strain, 80612% of muscle (green) cells showed
responses to 1 mM GABA application whereas no GABA-
activated currents were detected from L1 muscle cells derived
from unc-49(e407) mutant [16], which lacks UNC-49 receptors.
1 mM GABA-elicited currents reach a peak in less than ,4 ms
(t20-80 = 462 ms, n = 13; Fig. 2A). The mean peak current (Ipeak)
is -21.7611 pA/pF at 270 mV. Currents decay in the continuous
presence of GABA to reach steady state current values (Iss) close to
zero (Iss/Ipeak = 0.0560.03), indicating full desensitization.
Decays are fitted by a double exponential function (tfast =
1969 ms and tslow = 85640 ms). At 10 mM GABA, peak
currents are between 4- and 5-fold larger than at 1 mM (2
105.7665 pA/pF, n= 9; Fig. 2A and B). Despite the variability in
current amplitudes among different cells, the difference between 1
and 10 mM GABA is statistically significant (Fig. 2B). Muscimol
(1 mM) also elicits GABA-activated currents from L1 muscle cells
with a mean peak current of 247.8613 pA/pF (n= 5), which is
statistically different from that of 1 mM GABA-currents (Fig. 2A
and B). 1 mM piperazine (PZE) does not elicit detectable currents.
However, 10 mM PZE elicits currents in ,76% of the cells,
indicating that PZE acts as an agonist of C. elegans UNC-49
receptors. Peak currents are smaller and statistically different to
those elicited by 10 mM GABA (Ipeak = 220613 pA/pF, n= 5;
Figure 1. Expression of GABA receptor in C. elegans muscle
cultured cells. Confocal microscopy of L1 muscle cells in culture from
worms expressing GFP in muscle (PD4251 strain, (A)) or associated to
GABA receptors (EG1653 strain, (B)). Left panels correspond to DIC and
Right panels correspond to fluorescence microscopy. Bar: 20 mm. (C)
Fluorescence intensity profile at the membrane level of representative
cells shown in panel B, two of which show GFP expression (marked by
green and red lines) and the other corresponds to the basal
fluorescence (blue line).
doi:10.1371/journal.pone.0095072.g001
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Fig. 2B). Increasing PZE concentration to 25 mM does not
produce larger currents than those elicited by 10 mM PZE (Ipeak
= 21.766 pA/pF n=3; p.0.30), suggesting that this drug does
not behave as a full agonist. Unfortunately, an extended
pharmacological study in the same cell is not possible because of
the seal stability and the resealing of the whole cell. Nevertheless,
the results suggest that PZE is less efficacious than GABA and
muscimol at C. elegans UNC-49 receptors.
Ivermectin (IVM) has been shown to activate and modulate a
large number of vertebrate and invertebrate Cys-loop receptors.
We therefore explored if it also affects GABA receptors from C.
elegans. Currents are not elicited by application of IVM, indicating
that it is not capable of activating GABA receptors (n = 6 cells).
Pre-exposure of L1 cells to 30 mM IVM during 2 min fully inhibits
1 mM GABA-responses (n = 6 cells) and inhibits 9063% of
10 mM PZE-responses (n = 8 cells, Fig. 2 C). Peak currents cannot
be recovered after 5-min wash with buffer alone, suggesting
apparent irreversibility. As a control, we verified that GABA-
activated currents are not inhibited when cells are pre-exposed 2
minutes to 0.1% DMSO in the absence of IVM (n= 3, peak
current .85% of the control peak). Thus, we conclude that IVM
acts as an inhibitor of C. elegans UNC-49 receptors.
Single-channel currents of GABA receptors from L1
muscle cells
To gain further insight of how anthelmintic drugs act on GABA
receptors we recorded single-channel currents from cell-attached
patches in L1 muscle cells. Single-channel openings are detected at
concentrations higher than 0.5 mM although they are very
infrequent at this concentration. The proportion of patches that
show detectable single-channel activity is very low at all GABA
concentrations. At 5 mM GABA, only ,15% of the patches show
detectable openings. Channel openings exhibit single amplitudes
of 2.560.6 pA at +100 mV pipette potential (Fig. 3A),
2.960.3 pA at +140 mV, and 3.560.2 pA at +160 mV (n= 6).
By the slope of the current-voltage relationship, we estimated a
value of 2260.8 pS (n = 6) for channel conductance.
No opening events were detected in the absence of GABA
(n= 30 cells) or in cell-attached patches from the unc-49(e407)
mutant (n = 10 cells), thus revealing that the observed channel
activity is originated from UNC-49 receptors.
At all GABA concentrations (1-10 mM), single-channel activity
occurs as isolated opening events and short bursts composed of
successive openings (Fig. 3A). Open-time distributions at all GABA
concentrations are well described by a single exponential
component with mean durations between ,0.18 and 0.40 ms
(Fig. 3A and Table 1). Bursts are readily detected at 5 mM GABA
and show a mean duration of 1.160.25 ms (n = 5; Fig. 3A). Closed
time distributions can be well fitted by three or four exponential
components (Fig. 3A). The duration of the main closed component
decreases with GABA concentration, indicating the increase in the
frequency of openings with agonist concentration (Fig. 3A and
Table 1).
Single UNC-49 channel activity is also detected in the presence
of 1 mM muscimol and 10 mM PZE (Fig. 3B). As expected, the
amplitude of opening events is similar to that of GABA-activated
channels (2.460.8 pA and 2.560.6 pA for 1 mM muscimol and
10 mM PZE, respectively, p.0.8; Fig. 3B). Mean open times
(Table 1) and burst durations (0.9460.29 ms and 1.260.14 ms for
1 mM muscimol and 10 mM PZE, respectively) are not statisti-
cally different from those of 5 mM GABA-activated channels (p.
0.4). The frequency of opening events from recordings in the
presence of 10 mM PZE is systematically lower than that of
10 mM GABA (See representative traces in Fig. 3). The reduced
frequency is clearly reflected in the closed time histograms by the
displacement to longer durations of the main closed component
(Fig. 3 and Table 1). This result is in agreement with the smaller
macroscopic responses elicited by PZE, again suggesting that this
drug is less efficacious than GABA.
Single-channel activity is not detected when IVM (20–40 mM)
alone is present in the pipette solution (n= 12 and n= 14 for 20
and 40 mM IVM, respectively), indicating that it is not capable of
Figure 2. Macroscopic responses of L1 muscle cells to GABAergic agonists. (A) Representative whole-cell currents from L1 cultured muscle
cells (PD4251 strain) elicited by a 1 s-pulse of GABA, muscimol and piperazine. Pipette potential:270 mV. Each current corresponds to a different cell
and represents the average of at least 2–4 applications of the same agonist per cell. (B) Percentage of the peak current normalized to that elicited by
10 mM GABA. ANOVA with Bonfferroni multi comparison post test. (* p,0.05, ** p,0.01). (C) Whole-cell currents activated by 1 mM GABA or 10 mM
PZE before (black line) and after pre-exposure to 30 mM IVM during 2 min (grey line).
doi:10.1371/journal.pone.0095072.g002
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activating C. elegans GABA receptors (Fig. 3). Also, GABA (1, 5 or
7 mM) does not elicit detectable single-channel activity if IVM is
present in the pipette solution (n = 24 and n=28 for 20 and
40 mM IVM, respectively; Fig. 3C). This result reveals that IVM
produces fast and apparently irreversible inhibition of GABA
receptors.
Effects of ivermectin on levamisole-sensitive AChRs
Since the L-AChR is the main Cys-loop receptor involved in
muscle contraction, we evaluated whether it is, as the muscle
GABA receptor, modulated by IVM. To this end, we took
advantage of our previous characterization of single-channel
activity of L-AChR on L1 cells [18,19]. As shown in Figure 4A,
single channels of L-AChRs activated by 50 mM ACh are readily
detected from L1 muscle cells. Channel activity shows openings of
3.560.3 pA (n= 5) at +100 mV pipette potential that appear
isolated or in short bursts (Fig. 4A, top trace). As previously
described [18,19,27], single-channel activity remains constant
during the course of the 15-min recording. In contrast, when
50 mM IVM is present in the pipette solution together with 50 mM
ACh, single-channel activity is detected at the beginning of the
recording but it dramatically decreases after the first minute; only
sporadic and infrequent activation episodes are observed thereaf-
ter (Fig. 4A, lower trace). As a control, we verified that 0.1%
DMSO does not produce any change in single-channel activity
(n = 5).
We also tested the effect of the pre-exposure of cells to 50 mM
IVM on single-channel activity. To this end, we incubated the
culture dishes for ,15–20 min with 0.1% DMSO in the absence
(Fig. 4B, top trace) or presence (Fig. 4B, lower trace) of 50 mM
IVM and recorded ACh-activated single-channel currents as
described above. In the first 30 seconds of recording, the number
of opening events is significantly reduced in IVM-treated cells and
it is statistically different from that of 0.1% DMSO-treated cells
(n = 5, p,0.01; Fig. 4C). To quantify the decrease of single-
channel activity as a function of time due to the presence of IVM,
Figure 3. Single-channel currents from GABA receptors recorded from cultured muscle cells. Single channels currents were recorded
from muscle cultured cells in the presence of GABA (1, 5 or 10 mM) (A) and 1 mM muscimol or 10 mM piperazine (PZE) (B). Representative channel
traces and open and closed time histograms are shown for each condition. (C) Representative traces of single-channel activity in the presence of IVM
alone (top traces) or together with 1 mM or 5 mM GABA in the pipette solution (bottom). Channel openings are shown as upward deflections.
Pipette potential: +100 mV. Filter: 9 kHz.
doi:10.1371/journal.pone.0095072.g003
Table 1. Single-channel properties of GABA receptors and levamisole-sensitive AChRs.
Agonist (mM) O1 (ms) (area) O2 (ms) (area) C2 (ms) (area) n
UNC-49 receptors
GABA 1 0.2660.04 (1) nd 11006300 (0.8560.03) 3
GABA 3 0.2060.03 (1) nd 2206140 (0.8060.07) 3
GABA 5 0.3960.09 (1) nd 180670 (0.7760.17) 9
GABA 10 0.1860.03 (1) nd 87670 (0.8560.01) 4
Muscimol 1 0.4060.17 (1) nd 9506500 (0.5760.09) 5
PZE 10 0.4060.11 (1) nd 19006400 (0.5860.14) 5
L-AChRs
ACh 0.05 0.2460.03 (0.8960.01) 0.4060.06 (0.1160.01) 13.6066.2 (0.7060.01) 5
ACh 0.05 + IVM 0.05 0.2660.07 (0.8760.08) 0.4160.16 (0.1760.04) 48.40620 (0.5860.11) 5
Single-channel currents were recorded from L1 muscle cells at a holding potential of +100 mV. GABA channels were recorded in the presence of GABA, muscimol and
piperazine in the pipette solution. ACh channels corresponding to L-AChRs were recorded in the presence of ACh with and without IVM in both pipette and dish
solutions. The data were obtained from the corresponding histograms and correspond to the average of different recordings (n) for each condition. nd: Non detected.
doi:10.1371/journal.pone.0095072.t001
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we measured the number of opening events per minute during the
first 5 min for each condition (Figure 4D). In the control, the
number of events remains constant during the course of the
recording (Fig. 4D and [19]). However, in the presence of IVM,
the frequency of events profoundly decreases after the first minute.
This is clearly illustrated by the percentage of events detected in
the first and second minute, which decreases from ,80% to
,10%, respectively.
The few opening events from IVM-treated cells were analyzed
to determine if the drug affects single-channel properties. Open
time histograms are fitted by the sum of two exponential
components, which are identical to those detected in the control
condition (Fig. 4E and Table 1). Closed-time distributions of L-
AChRs from both conditions are well described by the sum of
three or four components. The main closed component is
displaced to longer durations in recordings from cells previously
treated with IVM (p,0.01; Fig. 4E and Table 1), in agreement
with the decreased frequency of opening events.
Taken together, our single-channel study reveals that muscle L-
AChR and GABA receptors are profoundly inhibited by IVM.
Behavioral effects of anthelmintic drugs
PZE produces flaccid paralysis and lengthening of parasitic and
C. elegans worms [5,28]. Since our results show that PZE is an
agonist of C. elegans UNC-49 channels in L1 cells, we also explored
drug sensitivity at this stage. 2 h-exposure of worms to 1-10 mM
PZE does not affect significantly worm locomotion whereas
25 mM PZE significantly affects worm behavior producing flaccid
paralysis. Under this condition,,40% adult and,20% L1 worms
are paralyzed after 2 h (Fig. 5A). The reduced sensitivity of L1
stage may be due to the fact that at this stage GABA receptors are
not present in dorsal muscle and are only present in ventral muscle
[29]. At 40 mM PZE ,90% of L1 worms are paralyzed after 2 h
on agar plates.
The features of IVM-induced paralysis have been well described
[30,31]. After 2-h exposure on agar plates containing 0.3 mM
IVM, worms are stationary but they still respond to prodding
(Fig. 5A). The combination of 0.3 mM IVM with 25 mM PZE
significantly enhances the flaccid paralysis produced by 25 mM
PZE alone, resulting in ,75% of adult and ,80% of L1 worms
that do not respond to prodding after 2 h (Fig. 5A). Thus, IVM
causes a synergic effect on PZE-induced paralysis at both stages.
As a control, we verified that no changes in worm behavior occur
in the presence of 1% DMSO alone. The PZE and IVM doses
used in both human and veterinary medicine appear to be high
(e.g. 50–110 mg/kg host weight for PZE and 0.2 –200 mg/kg host
weight for IVM [32–37]), in close agreement with the concentra-
tions required to show effects in our assays.
To gain further insights into IVM targets, we used the triple
mutant strain on GluClRs subunits, avr-14(ad1302);avr-
15(ad1051);glc-1(pk54), which has been shown to exhibit high
resistance to IVM [31]. Non statistical differences in the sensitivity
to 40 mM PZE on agar plates are detected between wild-type and
triple mutant worms (Fig 5B). In contrast, PZE-induced paralysis is
enhanced by the presence of 0.3 mM IVM in wild-type, as shown
above, but not in triple mutant worms (Fig. 5B), thus suggesting
Figure 4. Modulation of L-AChRs of L1 muscle cells by ivermectin. (A) Single-channels activated by 50 mM ACh were recorded in the absence
(top) and presence of 50 mM IVM in the pipette solution (bottom). Three different traces are shown for each condition and correspond to the
recording during the first, third and fifth minute. (B) Representative traces of single-channels activated by 50 mM ACh were recorded in the absence
(top) and presence of 50 mM IVM in the pipette solution (bottom) from cells previously incubated with 0.1% DMSO (top) or 50 mM IVM in 0.1% DMSO
(bottom). In brackets it is indicated the pre-incubation condition (0.1% DMSO for the control and 0.1% DMSO plus 50 mM IVM. (C) Comparison of the
number of opening events in the first 30 seconds of recording as in (B). ** p,0.01 (Student t-Test). (D) Bar chart showing the percentage of opening
events per minute during the first 5-min recording as in (B). The data correspond to five different recordings for each condition. (E) Representative
traces and open and closed time histograms of channels recorded as explained in Panel B. Traces are shown at two temporal scales. Pipette potential:
+100 mV. Filter: 9 kHz.
doi:10.1371/journal.pone.0095072.g004
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that GluClRs are involved in the IVM potentiation of PZE
paralysis.
Thrashing assays in the presence of 10 mM IVM show that
100% of wild-type worms are stationary. The triple mutant worms
show a reduction of 50% in the thrashing rate (Fig. 5C), suggesting
that other receptors besides GluClRs may contribute to the IVM
effect, at the micromolar range, on worm locomotion [31].
Discussion
The prevalence of human and animal helminth infections
remains staggeringly high, thus urging the need for concerted
efforts towards this area of research [38,39]. GABA receptors,
encoded by the unc-49 gene, mediate body muscle inhibition
during locomotion in C. elegans and parasitic nematodes and are
therefore important targets of anthelmintic drugs [2,12,13,16].
Thus, the molecular and pharmacological characterization of
these nematode receptors will have important implications for the
development of novel anthelmintic drugs as well as for our
understanding of GABA receptor pharmacology.
We here identified functional muscle GABA receptors com-
posed of UNC-49 subunits in C. elegans L1 muscle cells. Not all L1
muscle cells do respond to GABA application, nor do they show
GFP-label associated to GABA receptors, in agreement with the
fact that at the L1 stage GABA receptors are expressed only in
body ventral muscles and not in body dorsal muscles [29,40].
Thus, our study gives further evidence that the L1 cell culture
reproduces the in vivo situation [21].
Overall responses of GABA receptors to anthelmintic drugs
were evaluated by measuring macroscopic currents from L1
muscle cells in the whole-cell configuration. Unfortunately, these
cultured muscle cells are not technically suitable for successive
drug applications and they therefore do not allow complete
pharmacological assays. This relatively limited information is
nevertheless still valuable when complemented with single-channel
recordings and behavioral assays.
Macroscopic currents elicited by GABA show rapid onset as
well as rapid and full decay under the sustained pulse of agonist,
indicating full desensitization [19]. At 1 mM, muscimol elicits
larger currents than those elicited by 1 mM GABA, indicating that
it is a full and potent agonist of C. elegans UNC-49 receptors as of
vertebrate GABAA receptors. In contrast, muscimol has been
shown to be less potent than GABA at Ascaris suum and Haemonchus
contortus receptors [12,41]. PZE is used to treat Ascaris lumbricoides
and Enterobius vermicularis infections in humans. Nematode paralysis
has been shown to be mediated by activation of GABA-currents in
A. suum [42]. We here show that it is also an agonist of C. elegans
muscle GABA receptors since it is capable of eliciting macroscopic
currents, which are of reduced amplitude when compared to
GABA-elicited currents.
C. elegans GABA currents have been recorded previously from
oocytes expressing either UNC-49B/C or UNC-49B subunits
[43]. The GABA-activated currents recorded from our L1
cultured cells seem to be more similar to those corresponding to
UNC-49B/C heteromers than to UNC-49B homomers, which
show significantly slower desensitization [43].
In spite of the low number of active patches and the few opening
events, we were able to describe the properties of single UNC-49
channels from L1 muscle cells. Channel openings activated by
GABA, muscimol or PZE exhibit single amplitudes of ,2.5 pA (+
100 mV pipette potential) and brief open durations. The opening
events are not detected in the absence of agonist or in patches from
the unc-49 null mutants, thus revealing that the observed channel
activity is originated from UNC-49 receptors. The lowest PZE
concentration that allows detectable opening events as well as the
frequency of opening events is reduced when compared to the
other agonists. These observations together with the reduced
macroscopic currents suggest that PZE is less efficacious than
GABA. In agreement with this conclusion, PZE has been shown to
act as a low-efficacy agonist of GABA receptors of the parasitic
nematodes A. suum [14,42] and H. contortus [44].
Up to our knowledge the only -though limited- description of
single C. elegans UNC-49 channel activity was made in HEK cells
transfected with UNC-49B and C subunits [16]. The estimated
conductance was ,37 pS for UNC-49B homomers and ,30 pS
for UNC-49B/C heteromers [16].This latter value is in close
agreement with the conductance determined from our single-
channel recordings from L1 cells (,22 pS) as well as with the
Figure 5. Measurement of sensitivity of C. elegans to PZE and
IVM. (A) Synchronized L1 and adult wild-type worms were placed on
plates containing the specified drug [25 mM Piperazine (PZE), and/or
300 mM ivermectin (IVM)], and observed at the indicated times to
determine the fraction of worms that respond to prodding, which were
considered as ‘‘moving worms’’. (B) Wild-type and triple mutant avr-
14(ad1302);avr-15(ad1051);glc-1(pk54) (DA1316 strain), adult worms
were placed on agar plates containing the specified drug [40 mM
PZE, and/or 300 mM IVM]. Each point represents the average of 3-5
experiments, n = 30 worms, error bars = SD. (C) Effect of IVM on
nematode swimming measured as thrashes per minute for wild type
and the triple mutant. Measurements were performed after 30 min of
incubation in M9 buffer or M9 buffer plus 10 mM IVM.
doi:10.1371/journal.pone.0095072.g005
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conductance determined for GABA receptors from A. suum (,22
pS, [45]). Thus, the comparison of the desensitization rate of
macroscopic currents and the single-channel conductance deter-
mined in our study with results from heterologously expressed
UNC-49 receptors suggests that receptors in L1 muscle cells may
be UNC49B/C heteromers, as previously reported for both C.
elegans and parasitic nematodes [9,43,44].
Although IVM has revolutionized the treatment of nematode
and arthropod parasites, much remains to be learned about how it
works and how resistant to it is developed [38]. The antiparasitic
effects of IVM are known to be mediated by paralysis of the
pharyngeal muscle through glutamate-gated chloride channel
receptors (GluClR) [17,46,47] and of the somatic muscle through
GABA receptors [48]. However, at the molecular level, IVM has
been shown to activate and modulate a great number of Cys-loop
receptors. IVM activates vertebrate GABA receptors, potentiates
GABA receptors from H. contortus and inhibits GABA receptors
from A. suum [5,49,50]. Our study reveals that it inhibits UNC-49
receptors from C. elegans. IVM inhibition appears to be irreversible
(currents cannot be recovered after 5-min wash) in agreement with
its reported actions at other anionic Cys-loop receptors [51]. IVM
action at GABA receptors is more similar between C. elegans and
the parasite A. suum than between the latter and H. contortus, in line
with the fact that C. elegans is no more dissimilar to parasitic
nematodes than each individual species of parasite is to another
[17,25].
Therefore, although GABA receptor subunit family appears
conserved among nematodes there are variations in the properties
of how individual channels respond to IVM among species.
Understanding the molecular bases of these differences may lead
to more rational and specific treatments.
With respect to AChRs, IVM has been shown to potentiate
vertebrate a7 AChRs [52] and to inhibit C. elegans N-AChRs
(ACR-16) [53] and a7-5HT3A chimeric receptors [54]. Our study
extends the information of IVM targets by showing that it inhibits
C. elegans L-AChR, which is the main excitatory receptor involved
in locomotion. Assuming that the few detected openings from
IVM-treated cells correspond to IVM-treated receptors, our
detailed single-channel study reveals that IVM fully inhibits
channel activity without affecting open-channel lifetime This
observation may be mechanistically explained by the stabilization
of desensitized states, inhibition of channel opening, or irreversible
channel block. In conclusion, our study reveals that IVM inhibits
C. elegans muscle GABA and AChR receptors, thus contributing to
the understanding of the wide spectrum of action of this complex
drug.
The crystal structure of GluClR complexed with IVM shows
that the drug binds at subunit interfaces on the periphery of
transmembrane domains between M3 on the principal subunit (+)
and M1 on the complementary subunit (-) and it makes important
contacts with the M2 pore-lining a-helix and the M2–M3 linker
[55]. However, the relationship between binding and channel
activation is not completely understood [56]. Based on the
structure of GluCl-IVM and on how different receptors are
activated or modulated by IVM, several residues in M2, M3 and
M1 domains have been pointed as involved in activation and
potentiation [51]. The comparison of these residues in UNC-49
subunits between C. elegans and H. contortus does not reveal a clear
pattern of substitutions which may explain why their GABA
receptors are oppositely modulated by IVM. Thus, this opposite
IVM modulation could be due to different changes elicited by
IVM binding rather than to IVM binding itself. In fact, mutations
in residues from other loops outside the IVM-binding site affect
the efficacy of IVM activation [54,57]. By molecular docking and
mutagenesis studies it has been suggested that the site of action of
IVM at AChRs may be located at an intrasubunit cavity (not
intersubunit as in the GluCl receptor) in the transmembrane
region [54,58]. Thus, the occupancy of different sites or/and the
intrinsic capability of each receptor to respond to IVM binding
may lead to the pleiotropic effects of this drug.
Understanding the mechanistic and structural bases underlying
the final response of IVM may not only be important for the
development of novel anthelmintic agents but also for drugs
targeting human Cys-loop receptors associated to neurological
diseases. In this respect, drugs that alter receptor responses to
normal released neurotransmitter, such as positive allosteric
modulators, are emerging as key therapeutic treatments for
neurodegenerative and neurological diseases [59].
The combination of drugs is a strategy tending to fight against
the increase in anthelmintic resistance. Despite being a low-
efficacy GABAergic agonist, PZE is capable of inducing flaccid
paralysis in C. elegans. We show that IVM can be used to potentiate
the paralysis induced by PZE (at both L1 and adult stages) and
that this potentiation may be mediated by GluClRs since it does
not occur in the triple mutant strain. The explanation for the
synergic effect seems to be not so straightforward since IVM
inhibits UNC-49 receptors but potentiates PZE flaccid paralysis.
However, IVM action is highly complex given its broad spectrum
of action [48]. Although understanding the neuronal circuit basis
underlying the synergic IVM-PZE effect requires further investi-
gation, our results suggest that the combination of the two drugs
may result in a good alternative strategy to overcome the ever
increasing resistance of parasites to these drugs, which is of global
concern for human and cattle health.
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